TL;DR
This study constructs a comprehensive competing endogenous RNA (ceRNA) network for coronary artery disease (CAD) by integrating lncRNA, miRNA, and mRNA expression data. The network highlights key regulatory molecules like KCNQ1OT1 and H19, and implicates pathways such as PI3K-Akt signaling in CAD pathogenesis, offering new insights into the disease's genetic mechanisms.
What Problem Does This Paper Address?
Coronary artery disease (CAD) remains a leading cause of mortality globally, yet its underlying genetic mechanisms are not fully understood. While microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are known to play crucial roles in various biological processes and diseases, their intricate regulatory interactions in CAD are complex and require systematic investigation. Specifically, understanding how these non-coding RNAs, along with messenger RNAs (mRNAs), form regulatory networks that contribute to CAD development is a significant challenge. This paper aims to address this gap by constructing and analyzing a lncRNA-miRNA-mRNA ceRNA network to identify key players and pathways involved in CAD.
Methods
The researchers employed a multi-omics approach to build the ceRNA network. They started by identifying differentially expressed genes (DEGs) across lncRNA, miRNA, and mRNA datasets from CAD patients and healthy controls. For miRNA-mRNA interactions, they utilized a consensus approach, requiring predicted interactions to be present in at least three different databases (miRMap, miRanda, miRDB, TargetScan, mirTarBase). LncRNA-miRNA interactions were sourced from the StarBase database. The ceRNA network was then constructed based on the principle that lncRNAs can sponge miRNAs, which in turn regulate mRNAs, creating a feedback loop. Finally, they performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses on the genes within the ceRNA network to understand their functional roles. Protein-protein interaction (PPI) network analysis was also conducted on the mRNAs in the ceRNA network to identify hub genes.
Datasets
The study utilized publicly available datasets from the Gene Expression Omnibus (GEO) database:
- lncRNA datasets: GSE69587 (3 control, 3 CAD samples) and GSE113079 (48 control, 93 CAD samples).
- miRNA dataset: GSE105449 (42 control, 38 CAD samples).
- mRNA datasets: GSE113079 (48 control, 98 CAD samples) and GSE9820 (13 control, 8 CAD samples for resting monocytes; 15 control, 19 CAD samples for macrophages).
Key Insights and Ideas
- Complex Regulatory Landscape: The study reveals a complex interplay of lncRNAs, miRNAs, and mRNAs in CAD, moving beyond single-molecule investigations to a network-level understanding.
- Hub Molecules Identified: KCNQ1OT1 and H19 emerge as critical lncRNAs with high connectivity to multiple miRNAs, suggesting their central roles in CAD regulation.
- Pathway Involvement: The ceRNA network is significantly enriched in pathways related to nitrogen compound metabolism, PI3K-Akt signaling, and retrograde endocannabinoid signaling, pointing to key biological processes affected in CAD.
- H19's Dual Role: The lncRNA H19, known for its context-dependent roles in cancer, is implicated in CAD, with previous studies suggesting it as a potential diagnostic marker.
- miRNA Significance: Several miRNAs, including has-miR-376a-3p and has-miR-27b-3p, are highlighted for their extensive interactions within the network.
Key Results
- Differential Expression: The study identified a substantial number of differentially expressed molecules: 1111 lncRNAs, 2595 mRNAs, and 22 miRNAs in CAD patients compared to controls.
- ceRNA Network Construction: Two ceRNA networks were constructed based on differentially expressed miRNAs and lncRNAs.
- Hub Genes in PPI Network: In the PPI analysis of mRNAs within the ceRNA network, GNB4 and GNG11 showed the highest connectivity.
- Functional Enrichment: GO analysis indicated involvement in nitrogen compound metabolic process, macromolecule metabolic process, and anatomical structure development. KEGG analysis highlighted inflammatory mediator regulation of TRP channels, PI3K-Akt signaling pathway, and retrograde endocannabinoid signaling.
Limitations and Future Work
- Experimental Validation: The paper acknowledges that the interactions within the ceRNA network are predicted and require experimental validation. While some studies have validated certain interactions (e.g., H19 in CAD diagnosis), comprehensive experimental confirmation of the entire network is a crucial next step.
- Limited miRNA-mRNA Interaction Databases: The reliance on a limited number of databases for miRNA-mRNA interaction prediction could miss some true interactions or include false positives.
- Specific Cell Types: While some analyses focused on monocytes and macrophages, CAD is a systemic disease affecting multiple cell types. Future work could explore ceRNA networks in other relevant cell types.
- Dynamic Changes: The time-series analysis provided insights into gene expression dynamics, but further investigation into the temporal regulation of the ceRNA network in CAD progression would be beneficial.
- Therapeutic Potential: The identified hub molecules and pathways offer potential targets for therapeutic intervention, which warrants further research and preclinical studies.
Summary updated